Destructive Effects of Prenatal WIN 55212-2 Exposure on Central Nervous System of Neonatal Rats

Destructive Effects of Prenatal WIN 55212-2 Exposure on Central Nervous System of Neonatal Rats

Background: Cannabinoid, particularly hashish and WIN 55212-2 (WIN), consumption during embryonic period may affect fetal growth, and the development of motor functioning, memory and cognitive functions. Therefore, the present study aimed to evaluate the effects of WIN 55212-2 during embryonic perio...

Full description

Bibliographic Details
Main Authors:	Mohammad Shabani, Kouros Divsalar, Mahyar Janahmadi
Format:	Article
Language:	English
Published:	Kerman University of Medical Sciences 2012-07-01
Series:	Addiction and Health
Online Access:	https://ahj.kmu.ac.ir/article_84573_bc29c81857d74d4b04a44c60d8ae918a.pdf

Similar Items

Microinjection of WIN55,212-2 as a Cannabinoid Agonist into the Basolateral Amygdala Induces Sensitization to Morphine in Rats
by: Marzieh Molaei, et al.
Published: (2014-11-01)

Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2
by: Julio Raul Chavez-Monteagudo, et al.
Published: (2022-03-01)

The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats
by: Samane Jahanabadi, et al.
Published: (2016-04-01)

Alterations in Rat Accumbens Dopamine, Endocannabinoids and GABA Content During WIN55,212-2 Treatment: The Role of Ghrelin
by: Chrysostomos Charalambous, et al.
Published: (2020-12-01)

Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
by: Oyku Zeynep Gercek, et al.
Published: (2020-07-01)

Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
by: Mario Pérez-Diego, et al.
Published: (2023-03-01)

A MALE MOUSE MODEL OF WIN 55,212-2 SELF-ADMINISTRATION TO STUDY CANNABINOID ADDICTION
by: María Del Mar Cajiao-Manrique, et al.
Published: (2023-10-01)

A male mouse model of WIN 55,212–2 self-administration to study cannabinoid addiction
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-03-01)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-05-01)

EFFECTS OF SYNTETIC CANNABINOID RECEPTOR LIGANDS WIN 55.212-2 AND ANANDAMID UPON IN VITRO ACTIVITY OF IMMUNOCOMPETENT CELLS
by: E. G. Lobanova
Published: (2014-07-01)

Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP)
by: Marta Marszalek-Grabska, et al.
Published: (2021-07-01)

WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
by: Xiangshu Xian, et al.
Published: (2016-11-01)

Neurotherapeutic potential of synthetic cannabinoid receptor agonist, WIN55,212-2 on Aluminium chloride and D-galactose- induced cognitive impairments in male Wistar rats
by: Onesimus, Mahdi
Published: (2021)

Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat
by: Gema Vera, et al.
Published: (2023-09-01)

Photoacoustic viscoelasticity assessment of prefrontal cortex and cerebellum in normal and prenatal valproic acid-exposed rats
by: Zahra Hosseindokht, et al.
Published: (2024-04-01)

WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels
by: Dongchen An, et al.
Published: (2021-04-01)

WIN55212-2 Modulates Intracellular Calcium via CB<sub>1</sub> Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells
by: Victor M. Pulgar, et al.
Published: (2022-09-01)

R-(+)-WIN55212-2 protects pericytes from ischemic damage and restores retinal microcirculatory patency after ischemia/reperfusion injury
by: Jiaojiao Wei, et al.
Published: (2023-10-01)

Capsazepine, a Transient Receptor Potential Vanilloid Type 1 (TRPV1) Antagonist, Attenuates Antinociceptive Effect of CB1 Receptor Agonist, WIN55,212-2, in the Rat Nucleus Cuneiformis
by: Abbas Haghparast, et al.
Published: (2011-08-01)

Capsazepine, a Transient Receptor Potential Vanilloid Type 1 (TRPV1) Antagonist, Attenuates Antinociceptive Effect of CB1 Receptor agonist, WIN55,212-2, in the Rat Nucleus Cuneiformis
by: Asghar Parvishan, et al.
Published: (2011-08-01)

Comparison of Duration of Spinal Anesthesia with Lidocaine or Lidocaine Plus Epinephrine between Addicts and Non-addicts
by: Afshin Mansourian, et al.
Published: (2012-12-01)

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
by: Luiz Guilherme H. S. Aragão, et al.
Published: (2021-10-01)

Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
by: Meng-Wei Ko, et al.
Published: (2022-10-01)

Prenatal Diagnosis and Management of Congenital Abnormalities of Central Nervous System
by: Ülkü Bayar, et al.
Published: (2006-12-01)

Exposure to prenatal stressors and infant autonomic nervous system regulation of stress
by: Sandra J. Weiss, et al.
Published: (2024-12-01)

Brain structural connectome in neonates with prenatal opioid exposure
by: Ramana V. Vishnubhotla, et al.
Published: (2022-09-01)

DIFFERENTIAL ALTERATIONS IN EXCITABILITY AND FUNCTIONAL CONNECTIVITY OF DORSAL AND VENTRAL HIPPOCAMPAL CA1 PYRAMIDAL NEURONS IN A RAT MODEL OF AUTISM INDUCED BY VALPROIC ACID
by: Mona Rahdar, et al.
Published: (2023-10-01)

Analysis of structural and functional central nervous system abnormalities associated with prenatal exposure to ethanol in children of primary school age
by: E. V. Fadeeva, et al.
Published: (2022-07-01)

Sex differences in neonatal outcomes following prenatal opioid exposure
by: Nethra K. Madurai, et al.
Published: (2024-03-01)

The Effect of Prenatal and Neonatal Fluoride Exposure to Morphine-Induced Neuroinflammation
by: Patrycja Kupnicka, et al.
Published: (2024-01-01)

Prenatal caffeine exposure modifies development and reflexes of neonates and anxiety of young adult mice
by: Jamaan , S. Ajarem, et al.
Published: (1996)

Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine
by: Alla Kushnir, et al.
Published: (2023-06-01)

Prenatal exposure to air pollution is associated with structural changes in the neonatal brain
by: Brendan Bos, et al.
Published: (2023-04-01)

Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study
by: Amber Lin, et al.
Published: (2022-09-01)

55715 Quantification of Neonatal THC Exposure Following Prenatal Marijuana Use
by: Stefanie Kennon-McGill, et al.
Published: (2021-03-01)

Role of magnetic resonance imaging in prenatal diagnostics of congenital malformations of central nervous system
by: Olga Chuvashova
Published: (2014-12-01)

The Assessment of the Usefulness of Prenatal Magnetic Resonance Imaging in the Diagnosis of Central Nervous System Defects
by: Magdalena Kołak, et al.
Published: (2021-09-01)

NEUROBEHAVIORAL CONSEQUENCES OF PRENATAL EXPOSURE TO PARTICULATE MATTER IN RATS
by: Diego Ruiz-Sobremazas, et al.
Published: (2023-10-01)

Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP
by: Hoda Ranjbar, et al.
Published: (2023-03-01)

WIN55,212-2 Attenuates Cognitive Impairments in AlCl<sub>3</sub> + <span style="font-variant: small-caps">d</span>-Galactose-Induced Alzheimer’s Disease Rats by Enhancing Neurogenesis and Reversing Oxidative Stress
by: Onesimus Mahdi, et al.
Published: (2021-09-01)